Wednesday, November 5, 2025
9:00 AM PT / 12:00 PM ET

Join Diana Aberion, Sr. Director of Audits and Inspection Management at Gilead Sciences, and Yelena Ionova, Senior Manager of Data Strategy and Analytics at Redica Systems, for a data-driven look at how manufacturers and sponsors can prepare effectively for Pre-Approval Inspections (PAIs) / Pre-License Inspections (PLIs).

Gain insight into how regulatory agencies determine inspection priorities, what differentiates PAI/PLI from routine inspections, and how to design a staged readiness approach that reduces risk across your supply chain.

Key Insights:

  • Anticipate Inspection Risk with Data – Discover how to use FDA inspection trends and risk indicators to predict when and where a PAI or PLI is most likely—and focus your readiness efforts accordingly.
  • Build a Smarter, Staged Readiness Plan – Learn how leading sponsors and CMOs structure phased inspection readiness across sites and partners to align GMP, commercial, and product milestones for approval success.
  • Avoid the Quality System and Data Integrity Pitfalls That Derail Approvals – See what the latest inspection data reveal about the most common causes of CRLs and how to benchmark your organization’s readiness against top industry performers.
Speakers:

Diana Aberion​

Sr. Director, Audits and Inspection Management, Global Quality, Gilead Sciences ​

Yelena Ionova

Senior Manager of Data Strategy and Analytics, Redica Systems

If you have trouble registering, please contact events@redica.com.